SEC 13F Intelligence

Altium Capital Management LLC / AQST

Altium Capital Management LLC’s Aquestive Therapeutics Inc Position

Does Altium Capital Management LLC own Aquestive Therapeutics Inc (AQST)? Not currently — the last reported position was 665.0K shares worth $3M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q1 2024
Shares
665.0K
% of Portfolio
+1.12%
Quarters Held
1
position exited

Position History AQST

Reported value by quarter
Q1 ’24: $3MQ1 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2024665.0K$3M+1.12%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of AQST.